Vol 93, No 1 (2022)
Guidelines / Expert consensus
Published online: 2021-11-25

open access

Page views 6027
Article views/downloads 882
Get Citation

Connect on Social Media

Connect on Social Media

Recommendations of procedures to follow in the case of ovarian lesions in girls

Justyna Luczak1, Wojciech Gorecki2, Dariusz Patkowski1, Maciej Baglaj3, Agnieszka Drosdzol-Cop4, Elzbieta Adamkiewicz-Drozynska5, Urszula Zaleska-Dorobisz6, Mateusz Patyk6, Lidia Hirnle7
Pubmed: 35072262
Ginekol Pol 2022;93(1):76-87.


This study presents current recommendations of the Polish Association of Pediatric Surgeons (PTChD) regarding diagnostics and treatment of ovarian lesions in girls. They are based on many years of the authors’ clinical experience as well as a review of international literature and include practical clinical guidelines. The recommendations were formulated in cooperation with the Polish Association of Pediatric Oncology and Hematology (PTOHD), Polish Pediatric and Adolescent Gynecology Section of the Polish Society of Gynecologists and Obstetricians (PTG) and Polish Pediatric Section of the Polish Society of Radiology (PLTR). Only better understanding of prepubertal ovarian biology and natural history of its pathology may help to introduce efficient and safe diagnostic and therapeutic strategies for girls. The prepared document has been supplemented with treatment algorithms.


Article available in PDF format

View PDF Download PDF file


  1. Gonzalez DO, Minneci PC, Deans KJ. Management of benign ovarian lesions in girls: a trend toward fewer oophorectomies. Curr Opin Obstet Gynecol. 2017; 29(5): 289–294.
  2. Chae HS, Rheu CH. Precocious pseudopuberty due to an autonomous ovarian follicular cyst: case report with a review of literatures. BMC Res Notes. 2013; 6: 319.
  3. Hermans AJ, Kluivers KB, Janssen LM, et al. Adnexal masses in children, adolescents and women of reproductive age in the Netherlands: A nationwide population-based cohort study. Gynecol Oncol. 2016; 143(1): 93–97.
  4. Łuczak J, Bagłaj M. Selecting treatment method for ovarian masses in children - 24 years of experience. J Ovarian Res. 2017; 10(1): 59.
  5. Ehdaivand S WHO classification. PathologyOutlines.com website. https://www.pathologyoutlines.com/topic/ovarytumorwhoclassif.html (2021.04.21).
  6. Renaud EJ, Sømme S, Islam S, et al. Ovarian masses in the child and adolescent: An American Pediatric Surgical Association Outcomes and Evidence-Based Practice Committee systematic review. J Pediatr Surg. 2019; 54(3): 369–377.
  7. Brookfield KF, Cheung MC, Koniaris LG, et al. A population-based analysis of 1037 malignant ovarian tumors in the pediatric population. J Surg Res. 2009; 156(1): 45–49.
  8. Łuczak J, Bagłaj M. Ovarian teratoma in children: a plea for collaborative clinical study. J Ovarian Res. 2018; 11(1): 75.
  9. Cecchetto G. Gonadal germ cell tumors in children and adolescents. J Indian Assoc Pediatr Surg. 2014; 19(4): 189–194.
  10. Pashankar F, Hale JP, Dang Ha, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016; 122(2): 230–237.
  11. Park JY, Kim DY, Suh DS, et al. Outcomes of surgery alone and surveillance strategy in young women with stage I malignant ovarian germ cell tumors. Int J Gynecol Cancer. 2016; 26(5): 859–864.
  12. Stanković ZB, Sedlecky K, Savić D, et al. Ovarian preservation from tumors and torsions in girls: prospective diagnostic study. J Pediatr Adolesc Gynecol. 2017; 30(3): 405–412.
  13. Heo SH, Kim JW, Shin SS, et al. Review of ovarian tumors in children and adolescents: radiologic-pathologic correlation. Radiographics. 2014; 34(7): 2039–2055.
  14. Rekomendacje Sekcji Ultrasonografii Polskiego Towarzystwa Ginekologicznego w zakresie badań ultrasonograficznych w ginekologii. 2015. http://www.usgptg.pl/media/dopobrania/rekomendacje2015/Rekomendacje_ginekologia_2015.pdf (2021.04.21).
  15. Kaloo PD, Louden KA, Khazali S, Hoy D, Cheltenham BS, Sadoon S, et al. Management of Suspected Ovarian Masses in Premenopausal Women Green–top Guideline No. 62. Royal College of Obstetricians and Gynaecologists/ British Society for Gynaecological Endoscopy. 2011. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_62.pdf (2021.04.21).
  16. Basta P, Bidzinski M, Kluz T, Nowak-Markwitz E, Olejek A, Sawicki W. Ovarian cancer: recognition and initial management — the recommendation of Polish Gynecological Society. Ginekologia i Perinatologia Praktyczna 2016;1(3):127–129. https://www.ptgin.pl/index.php/lekarze/rekomendacje2/rekomendacje (2021.04.21).
  17. Czekierdowski A. Novel ultrasonography and prognostic models in the preoperative discrimination of ovarian cancer. Ginekologia i Perinatologia Praktyczna 2016;1(4:152–161. 2016; 1(4): 152–161.
  18. Stankovic ZB, Bjelica A, Djukic MK, et al. Value of ultrasonographic detection of normal ovarian tissue in the differential diagnosis of adnexal masses in pediatric patients. Ultrasound Obstet Gynecol. 2010; 36(1): 88–92.
  19. Lam CZ, Chavhan GB. Magnetic resonance imaging of pediatric adnexal masses and mimics. Pediatr Radiol. 2018; 48(9): 1291–1306.
  20. Al Musalhi K, Al Kindi M, Al Aisary F, et al. Evaluation of HE4, CA-125, risk of ovarian malignancy algorithm (ROMA) and Risk of Malignancy Index (RMI) in the preoperative assessment of patients with adnexal mass. Oman Med J. 2016; 31(5): 336–344.
  21. Wei SU, Li H, Zhang B. The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer. Biomed Rep. 2016; 5(1): 41–44.
  22. Romagnolo C, Leon AE, Fabricio ASC, et al. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study. Gynecol Oncol. 2016; 141(2): 303–311.
  23. Sölétormos G, Duffy MJ, Othman Abu Hassan S, et al. Clinical use of cancer biomarkers in epithelial ovarian cancer: updated guidelines from the European Group on Tumor Markers. Int J Gynecol Cancer. 2016; 26(1): 43–51.
  24. Gonzalez DO, Cooper JN, Aldrink JH, et al. Variability in surgical management of benign ovarian neoplasms in children. J Pediatr Surg. 2017; 52(6): 944–950.
  25. Aldrink JH, Gonzalez DO, Sales SP, et al. Using quality improvement methodology to improve ovarian salvage for benign ovarian masses. J Pediatr Surg. 2017 [Epub ahead of print].
  26. Łuczak J, Bagłaj M, Ciaputa R, et al. Does open ovarian biopsy in prepubertal age affect ovarian reserve in a rat model? J Pediatr Surg. 2021; 56(2): 360–367.